Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

266 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Johnson & Johnson, Q1 2024 Earnings Call, Apr 16, 2024
Johnson & Johnson: EPS up to $2.20 in Q1
CF
Johnson & Johnson 1Q Sales Rise on U.S. Growth, Cuts Adjusted EPS Outlook
DJ
Johnson & Johnson : 2024 First-Quarter Press Release & Supplemental Schedules
PU
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
BU
Johnson & Johnson to Acquire Shockwave Medical
AQ
Johnson & Johnson Seeks M&A
CI
Transcript : Johnson & Johnson, Shockwave Medical, Inc. - M&A Call
Johnson & Johnson to Acquire Shockwave Medical
BU
Transcript : Johnson & Johnson Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 01:00 PM
Johnson & Johnson : Leerink Global Biopharma Conference Transcript
PU
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
BU
US Senate Democrats grill pharma CEOs on drug prices
RE
Merck, J&J, Bristol Myers CEOs to Testify in Congress on Drug Prices
DJ
Transcript : Johnson & Johnson, Q4 2023 Earnings Call, Jan 23, 2024
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
BU
Transcript : Johnson & Johnson Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
BU
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BU
Transcript : Johnson & Johnson - Special Call
Johnson & Johnson: long-term objectives unveiled
CF
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
BU
Health Up as Pfizer Slides -- Health Care Roundup
DJ
J&J: Eugene A. Woods joins the Board of Directors
CF
Johnson & Johnson Names Eugene Woods as Board Member
DJ
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
BU
Johnson & Johnson to Host Enterprise Business Review
BU
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
BU
What You Need to Know About Johnson & Johnson's 2023 Third-Quarter Earnings
AQ
Transcript : Johnson & Johnson, Q3 2023 Earnings Call, Oct 17, 2023
Johnson & Johnson : 2023 Third-Quarter Press Release & Supplemental Schedules
PU
Johnson & Johnson Reports Q3 2023 Results
BU
Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline
RE
Johnson & Johnson : JNJ USQ Transcript 2023 09 13
PU
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
BU
Transcript : Johnson & Johnson Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 10:10 AM
Johnson & Johnson : Guidance Press Release with attachments
PU
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
BU
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc
AQ
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
BU
Johnson & Johnson completed the Split-Off of 80.1% stake in Kenvue Inc..
CI
Johnson & Johnson completed the Split-Off of 80.1% stake in Kenvue Inc..
CI
Johnson & Johnson completed the Split-Off of 80.1% stake in Kenvue Inc..
CI
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
BU
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc
AQ
Johnson & Johnson to Launch Exchange Offer for Kenvue Shares
DJ
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
BU
Johnson & Johnson : JNJ-Q2 2023 Transcript Final
PU
Transcript : Johnson & Johnson, Q2 2023 Earnings Call, Jul 20, 2023
Johnson & Johnson : 2023 Second-Quarter Press Release & Supplemental Schedules
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Joaquin Duato
  4. News